Conference Coverage ESC Congress 2019 See All Content See past conferences Paris, France August 31, 2019 September 04, 2019 News Conference News ESC 2019 Primary Prevention ICDs Still Render Better Survival, Even in Modern HFrEF Patients Though limited by its observational design, the study supports current recommendations for ICD use. < > Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease L.A. McKeown September 05, 2019 Ten-Year SYNTAXES Results Fix Roles for CABG, PCI in Complex CAD Shelley Wood September 05, 2019 New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises Michael O'Riordan September 04, 2019 ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date Yael L. Maxwell September 03, 2019 News News Conference News ESC 2019 GARFIELD-AF Analysis Digs Into Impact of Bleeding in Newly Diagnosed A-fib Todd Neale September 12, 2019 News Conference News ESC 2019 Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis Yael L. Maxwell September 12, 2019 News Conference News ESC 2019 Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints Todd Neale September 11, 2019 News Conference News ESC 2019 BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI Caitlin E. Cox September 10, 2019 Slides Presentation ESC 2019 THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes Presenter: Deepak Bhatt September 01, 2019 Presentation ESC 2019 Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome Presenter: Johannes Neumann September 01, 2019 Presentation ESC 2019 One-year Outcomes After ST Elevation Myocardial Infarction Presenter: Uwe Zeymer September 01, 2019 Presentation ESC 2019 PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years Presenter: Darryl P. Leong September 02, 2019 @TCTMD Follow Us
News Conference News ESC 2019 Primary Prevention ICDs Still Render Better Survival, Even in Modern HFrEF Patients Though limited by its observational design, the study supports current recommendations for ICD use.
Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease L.A. McKeown September 05, 2019
New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises Michael O'Riordan September 04, 2019
ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date Yael L. Maxwell September 03, 2019
News Conference News ESC 2019 GARFIELD-AF Analysis Digs Into Impact of Bleeding in Newly Diagnosed A-fib Todd Neale September 12, 2019
News Conference News ESC 2019 Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis Yael L. Maxwell September 12, 2019
News Conference News ESC 2019 Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints Todd Neale September 11, 2019
News Conference News ESC 2019 BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI Caitlin E. Cox September 10, 2019
Presentation ESC 2019 THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes Presenter: Deepak Bhatt September 01, 2019
Presentation ESC 2019 Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome Presenter: Johannes Neumann September 01, 2019
Presentation ESC 2019 One-year Outcomes After ST Elevation Myocardial Infarction Presenter: Uwe Zeymer September 01, 2019
Presentation ESC 2019 PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years Presenter: Darryl P. Leong September 02, 2019